- Report
- October 2025
- 82 Pages
Global
From €4232EUR$4,500USD£3,531GBP
- Report
- October 2025
- 89 Pages
Global
From €4232EUR$4,500USD£3,531GBP
- Report
- July 2025
- 111 Pages
Global
From €3245EUR$3,450USD£2,707GBP
- Report
- June 2025
- 78 Pages
Middle East, Africa
From €3245EUR$3,450USD£2,707GBP
- Report
- June 2025
- 101 Pages
Global
From €3245EUR$3,450USD£2,707GBP
- Report
- June 2025
- 93 Pages
Asia Pacific
From €3715EUR$3,950USD£3,099GBP
- Report
- June 2025
- 181 Pages
Global
From €4655EUR$4,950USD£3,884GBP
- Report
- June 2025
- 92 Pages
Europe
From €3715EUR$3,950USD£3,099GBP
- Report
- June 2025
- 82 Pages
North America
From €3245EUR$3,450USD£2,707GBP
- Report
- June 2025
- 76 Pages
From €3245EUR$3,450USD£2,707GBP
- Report
- March 2025
- 148 Pages
Global
From €4373EUR$4,650USD£3,648GBP
- Report
- July 2023
- 224 Pages
Global
From €4232EUR$4,500USD£3,531GBP
- Report
- April 2023
- 74 Pages
Global
From €3500EUR$3,986USD£3,022GBP
- Report
- September 2023
- 111 Pages
Global
From €3500EUR$3,986USD£3,022GBP
- Report
- September 2023
- 93 Pages
Global
From €3500EUR$3,986USD£3,022GBP
- Report
- November 2024
- 86 Pages
Global
From €3500EUR$3,986USD£3,022GBP
- Report
- October 2024
- 118 Pages
Global
From €3500EUR$3,986USD£3,022GBP
- Report
- October 2023
- 96 Pages
Global
From €3500EUR$3,986USD£3,022GBP
- Report
- May 2025
- 41 Pages
United States
From €959EUR$1,020USD£800GBP

The IV Solution market is a segment of the medical device industry that focuses on the production and distribution of intravenous solutions. These solutions are used to deliver medications, nutrients, and other fluids directly into a patient's bloodstream. IV solutions are typically packaged in bags, bottles, or syringes and are available in a variety of concentrations and sizes. They are used in a variety of medical settings, including hospitals, clinics, and home care.
The IV Solution market is highly competitive, with a wide range of products available from a variety of manufacturers. Companies in the market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, ICU Medical, and Terumo Corporation. Show Less Read more